Media

Press Releases

 

Mar 12 2013 Novel Test for Heart Problems to be Launched at Healthcare Innovation Expo 2013
Nov 28 2012 Rutgers provides exclusive license for non-invasive cardiovascular disease monitoring sensor technology to Everist Genomics
Nov 21 2012 Novel Test for Heart Problems Gets European Stamp of Approval
Jul 10 2012 Everist Genomics to Open New Laboratory in San Diego
Jun 04 2012 Everist Genomics Announces Publication of Validation Study Confirming OncoDefender-CRC Independently Predicts Recurrence Risk for Early Stage Colorectal Cancer Patients
May 22 2012 US-Based Everist Genomics Bucks the Outsourcing Trend and Accelerates Growth Through India
Mar 14 2012 Everist Genomics Develops World's First Comprehensive Companion Diagnostics and Prognostics Portfolio for Early Diagnosis and Improved Treatment of Colorectal Cancer
Feb 13 2012 Everist Genomics Celebrates Origins and Future of Personalized Medicine
Jan 27 2012 Smartphone Technology Meets Personalized Medicine in Everist Genomics' CardioDefender Diagnostic System
Dec 06 2011 Everist Genomics Discovers Genes Responsible for Recurrence of Colorectal Cancer
Nov 09 2011 Everist Genomics to Launch CardioDefender: World's Only Mobile ECG System that Delivers Real-Time, Beat-by-Beat, Quantitative Heart Monitoring Data to Physicians
Oct 31 2011 Everist Genomics Announces Acquisition of Angiologix, Inc.
Jun 03 2011 Everist Genomics Announces New Data on OncoDefender™-CRC Test for Predicting Recurrence Risk for Stage I and II Colorectal Cancer Patients
Apr 26 2011 Everist Genomics Announces Nobel Prize Winning Biochemist Dr. Kary Mullis To Give Keynote Speech at Gala Dinner
Mar 07 2011 Everist Genomics Laboratory Receives Approval from U.S. Regulatory Authorities for High Complexity Clinical Testing
Jan 20 2011 Everist Genomics Announces External Validation of OncoDefender™-CRC Test for Predicting Recurrence Risk for Stage I and II Colorectal Cancer Patients
Jan 10 2011 Genetics Squared Changes Name to Everist Genomics